HomeCompareQNNTF vs STAG

QNNTF vs STAG: Dividend Comparison 2026

QNNTF yields 2000.00% · STAG yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QNNTF wins by $9939315158.51M in total portfolio value
10 years
QNNTF
QNNTF
● Live price
2000.00%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9939315158.53M
Annual income
$9,049,252,674,478,578.00
Full QNNTF calculator →
STAG
STAG Industrial Inc.
● Live price
3.44%
Share price
$36.06
Annual div
$1.24
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.3K
Annual income
$462.70
Full STAG calculator →

Portfolio growth — QNNTF vs STAG

📍 QNNTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQNNTFSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QNNTF + STAG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
QNNTF pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QNNTF
Annual income on $10K today (after 15% tax)
$170,000.00/yr
After 10yr DRIP, annual income (after tax)
$7,691,864,773,306,791.00/yr
STAG
Annual income on $10K today (after 15% tax)
$292.69/yr
After 10yr DRIP, annual income (after tax)
$393.29/yr
At 15% tax rate, QNNTF beats the other by $7,691,864,773,306,398.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QNNTF + STAG for your $10,000?

QNNTF: 50%STAG: 50%
100% STAG50/50100% QNNTF
Portfolio after 10yr
$4969657579.27M
Annual income
$4,524,626,337,239,520.00/yr
Blended yield
91.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

QNNTF
No analyst data
Altman Z
-79.6
Piotroski
4/9
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+24.8% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QNNTF buys
0
STAG buys
0
No recent congressional trades found for QNNTF or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQNNTFSTAG
Forward yield2000.00%3.44%
Annual dividend / share$2.00$1.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0.3%
Portfolio after 10y$9939315158.53M$18.3K
Annual income after 10y$9,049,252,674,478,578.00$462.70
Total dividends collected$9876141646.27M$4.0K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: QNNTF vs STAG ($10,000, DRIP)

YearQNNTF PortfolioQNNTF Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$210,700$200,000.00$10,665$345.38+$200.0KQNNTF
2$4,163,767$3,938,317.76$11,365$358.01+$4.15MQNNTF
3$77,191,133$72,735,902.82$12,099$370.76+$77.18MQNNTF
4$1,342,813,676$1,260,219,163.76$12,870$383.63+$1342.80MQNNTF
5$21,925,333,121$20,488,522,486.99$13,678$396.60+$21925.32MQNNTF
6$336,109,296,351$312,649,189,912.21$14,526$409.67+$336109.28MQNNTF
7$4,838,913,266,619$4,479,276,319,522.88$15,413$422.82+$4838913.25MQNNTF
8$65,446,276,951,058$60,268,639,755,775.59$16,343$436.05+$65446276.93MQNNTF
9$831,834,097,245,644$761,806,580,908,011.90$17,315$449.35+$831834097.23MQNNTF
10$9,939,315,158,531,418$9,049,252,674,478,578.00$18,332$462.70+$9939315158.51MQNNTF

QNNTF vs STAG: Complete Analysis 2026

QNNTFStock

Quantum Genomics Société Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It develops drugs based on brain aminopeptidase A inhibition (BAPAI) platform primarily to treat high blood pressure and heart failure. The company develops firibastat, a monotherapy drug that is in pivotal Phase III study for the treatment of hypertension, as well as in clinical trial for the treatment of heart failure. It is also developing QGC011 to treat hypertension with combination therapy; and QGC006 and QGC606 drug for the treatment of hypertension and heart failure. The company was incorporated in 2005 and is based in Paris, France.

Full QNNTF Calculator →

STAGREIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →
📬

Get this QNNTF vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QNNTF vs SCHDQNNTF vs JEPIQNNTF vs OQNNTF vs KOQNNTF vs MAINQNNTF vs PLDQNNTF vs EQRQNNTF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.